Novel therapeutic strategies against highly aggressive cancers that, by simultaneously blocking two distinct molecular targets involved in cell division, synergize to deliver superior treatment performance at lower toxicities.
Small Molecule Platform for Aggressive Cancers
UG
Last Updated:
Last Updated:
Principal Investigators
Related News
Innovation Training for ARC Hub for Therapeutics Translational Researchers
To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
New €31.6 million ARC Hub for Therapeutics to turn breakthrough Irish research into therapies and companies
On December 3rd, 2025, we marked a major milestone for Ireland’s therapeutics ecosystem. The launch of the ARC Hub for Therapeutics was an energising and inspiring day, bringing together a brilliant community of academics, investors, funders, policymakers, and...